Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

China Pioneer, a Medical Device Distributor, Pays $33 Million for Stake in Australia's Paragon Care

publication date: Aug 27, 2018

China Pioneer Pharma Holdings, a medical device distributor, paid $33.2 million for a 15% stake in Australia's Paragon Care, a medical device maker. The two companies plan to cross-sell products in their respective markets. Paragon said it would use the cash to fund acquisitions of healthcare businesses in Australia and New Zealand. Pioneer has not previously been involved in the Australia or New Zealand drug distribution markets. More details....

Stock Symbols: (HK: 1345) (ASX:PGC)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.